InDevR provides new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include VaxArray portfolio of its game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.
Type | Private | |
Founded | 2003 | |
HQ | Boulder, CO, US | Map |
Website | indevr.com | |
Employee Ratings | More | |
Overall Culture | C- | More |
Employees (est.) (Apr 2022) | 33 | (-2%) |
Cybersecurity rating | B | More |
Founding Date | 2003 |
InDevR total Funding | $7 m |
InDevR latest funding size | $7 m |
Time since last funding | 3 years ago |
InDevR investors | Adjuvant Capital |
InDevR has 339 Twitter Followers. The number of followers has decreased 0.3% month over month and decreased 0.2% quarter over quarter
C-
69/100
A-
80/100
D
55/100
When was InDevR founded?
InDevR was founded in 2003.
Who are InDevR key executives?
InDevR's key executives are Kathy Rowlen, Terry Salyer and Glenn Rockman.
How many employees does InDevR have?
InDevR has 33 employees.
Who are InDevR competitors?
Competitors of InDevR include Fujifilm Diosynth Biotechnologies, Elektrofi and SeraCare.
Where is InDevR headquarters?
InDevR headquarters is located at 2100 Central Ave #106, Boulder.
Where are InDevR offices?
InDevR has an office in Boulder.
How many offices does InDevR have?
InDevR has 1 office.
Receive alerts for 300+ data fields across thousands of companies